冠心病患者二级预防规范化治疗效果随访研究  

Effectiveness of Standardized Management for Secondary Prevention of Coronary Heart Disease:A Follow-up Study

作　　者：王高频[1] 刘国銮[1] 杨雪佳[1] 马海芳[1] 

机构地区：[1]辽宁医学院附属第一医院心内科,辽宁省锦州市121001

出　　处：《中国全科医学》2012年第8期831-833,共3页Chinese General Practice

摘　　要：目的对冠心病患者危险因素及二级预防的情况进行调查,以了解冠心病二级预防的效果。方法对明确诊断为冠心病并住院的110例患者进行问卷调查及定期随访,按照二级预防规范化管理对其进行健康教育、治疗指导,记录冠心病危险因素及二级预防情况。结果与住院前比较,110例冠心病患者出院后对冠心病危险因素的知晓率、控制率及二级预防服药率均有明显提高(P<0.05);与住院时比较,冠心病患者二级预防药物服药率除抗血小板药物阿司匹林外,他汀类调脂药、β-受体阻滞剂、血管紧张素转化酶抑制剂或血管紧张素受体拮抗剂的长期服药率均有明显下降(P<0.05)。结论冠心病患者住院后,经二级预防规范化管理后对冠心病危险因素的知晓率、控制率及二级预防药物服药率明显提高;冠心病二级预防规范化管理是提高冠心病患者二级预防依从性的重要手段之一。Objective To investigate the risk factors for coronary heart disease （CHD） and the effectiveness of stand- ardized management for the secondary prevention of CHD. Methods A total of 110 CHD patients who had been ever hospitalized in the past years were enrolled to receive questionnaire - based survey and regular follow - up. Based on the standardized manage- ment protocol for secondary prevention, health education and medication instructions were provide, and the risk factors and theapplication of secondary prevention were recorded. Results Compared with the situations before hospitalization, the awareness and control of risk factors and the medication were remarkably improved after hospitalization among these 1l0 CHD patients （ P 〈 O. 05）. Compared with the situations during hospitalization, the administration of lipid - lowering statins, β - blockers, angio-tensin converting enzyme inhibitors （ except asprin） was decreased significantly （ P 〈 0. 05）. Conclusion The standardized management for the secondary prevention of CHD increases the patients＇ awareness of the risk factors of CHD, improves the con- trol of these risk factors, and reduces drug administration. It also provides a useful approache to increasing the CHD patients＇ compliance of secondary prevention.

关 键 词：冠心病 二级预防 随访研究 

分 类 号：R541.4[医药卫生—心血管疾病]